X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (7299) 7299
Book Review (704) 704
Publication (691) 691
Newsletter (277) 277
Book Chapter (40) 40
Conference Proceeding (36) 36
Dissertation (8) 8
Book / eBook (7) 7
Newspaper Article (7) 7
Magazine Article (5) 5
Government Document (4) 4
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (6035) 6035
tamoxifen (4617) 4617
humans (4336) 4336
female (3642) 3642
animals (2575) 2575
tamoxifen - pharmacology (2380) 2380
breast cancer (2155) 2155
biochemistry & molecular biology (2062) 2062
breast neoplasms - drug therapy (1522) 1522
oncology (1477) 1477
estrogen (1303) 1303
cancer (1238) 1238
breast neoplasms - pathology (1113) 1113
mice (1083) 1083
tamoxifen - analogs & derivatives (969) 969
rats (924) 924
receptors, estrogen - metabolism (916) 916
tamoxifen - therapeutic use (911) 911
breast neoplasms - metabolism (882) 882
expression (882) 882
cell line, tumor (856) 856
breast-cancer (855) 855
cell biology (855) 855
estradiol - pharmacology (834) 834
middle aged (814) 814
pharmacology & pharmacy (788) 788
research (778) 778
estrogen antagonists - pharmacology (734) 734
male (661) 661
endocrinology & metabolism (657) 657
postmenopausal women (652) 652
aged (643) 643
analysis (630) 630
apoptosis (590) 590
breast neoplasms - genetics (588) 588
breast neoplasms - chemistry (587) 587
receptors, estrogen - analysis (578) 578
adult (576) 576
tumor cells, cultured (548) 548
care and treatment (547) 547
cells (526) 526
estrogen-receptor (522) 522
tamoxifen - metabolism (505) 505
gene expression (497) 497
article (479) 479
estradiol (477) 477
chemistry, medicinal (473) 473
therapy (470) 470
tamoxifen - chemistry (462) 462
estrogen receptor (460) 460
antineoplastic agents, hormonal - therapeutic use (456) 456
health aspects (443) 443
dose-response relationship, drug (429) 429
proteins (422) 422
activation (420) 420
antineoplastic agents, hormonal - pharmacology (416) 416
chemotherapy (414) 414
cell proliferation - drug effects (411) 411
growth (410) 410
mcf-7 cells (405) 405
tumors (394) 394
tamoxifen - administration & dosage (390) 390
in-vitro (384) 384
time factors (378) 378
estrogens (374) 374
gene-expression (374) 374
biochemistry (367) 367
prognosis (355) 355
estrogen receptor alpha - metabolism (351) 351
ligands (350) 350
estradiol - analogs & derivatives (348) 348
antineoplastic agents - pharmacology (345) 345
phenols (345) 345
tamoxifen resistance (344) 344
receptors, estrogen - genetics (343) 343
cell line (342) 342
research article (341) 341
skin and connective tissue diseases (333) 333
immunohistochemistry (331) 331
signal transduction (331) 331
endocrine therapy (327) 327
medicine (325) 325
physiological aspects (324) 324
treatment outcome (321) 321
chemistry, multidisciplinary (314) 314
antiestrogens (310) 310
inhibition (307) 307
cell division - drug effects (306) 306
women (304) 304
structure-activity relationship (298) 298
apoptosis - drug effects (297) 297
genetic aspects (297) 297
receptors (297) 297
drug resistance, neoplasm (292) 292
proliferation (292) 292
binding (291) 291
drug therapy (290) 290
prevention (288) 288
phosphorylation (287) 287
receptors, progesterone - analysis (286) 286
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (7541) 7541
French (18) 18
Chinese (15) 15
Japanese (15) 15
German (12) 12
Russian (9) 9
Korean (5) 5
Spanish (4) 4
Dutch (2) 2
Hungarian (2) 2
Italian (2) 2
Czech (1) 1
Hebrew (1) 1
Norwegian (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Controlled Release, ISSN 0168-3659, 11/2015, Volume 217, pp. 243 - 255
Macrophages are innate immune cells with great phenotypic plasticity, which allows them to regulate an array of physiological processes such as host defense,... 
Obesity | Theranostic nanoparticles | Intravital imaging | Inflammation | Magnetic resonance imaging | Atherosclerosis | CORE-SHELL NANOPARTICLES | ATHEROSCLEROTIC PLAQUES | CONTRAST AGENTS | DRUG-DELIVERY | PHOSPHOLIPASE A | CHEMISTRY, MULTIDISCIPLINARY | ENDOTHELIAL-CELLS | INTRACELLULAR DELIVERY | PPAR-GAMMA | PHARMACOLOGY & PHARMACY | EXPRESSION | ADIPOSE-TISSUE | Nanoparticles - chemistry | Obesity - immunology | Polyethylene Glycols - chemistry | Thiazolidinediones - chemistry | Thiazolidinediones - administration & dosage | Tamoxifen - administration & dosage | Polystyrenes - chemistry | Cholesterol - chemistry | Paclitaxel - chemistry | Fluorescein-5-isothiocyanate - chemistry | Tamoxifen - chemistry | Anti-Inflammatory Agents - administration & dosage | Paclitaxel - administration & dosage | Cytokines - genetics | Macrophages - immunology | Phospholipases A2 - chemistry | Cell Line | Cholesterol - analogs & derivatives | Atherosclerosis - immunology | Mice, Inbred C57BL | Phosphatidylserines - chemistry | Gadolinium - chemistry | Mice, Knockout | Animals | Anti-Inflammatory Agents - chemistry | Apolipoproteins E - genetics | Macrophages - drug effects | Nanoparticles - administration & dosage | Phosphatidylethanolamines - chemistry | Phagocytosis | Nanoparticles | Drugs | Drug delivery systems | Physiological aspects | Lipids | Macrophages | Vehicles | Fluorescein | Cardiovascular agents | Index Medicus
Journal Article
Journal Article
Journal Article
Journal Article
Journal Article
Environmental Science and Pollution Research, ISSN 0944-1344, 5/2010, Volume 17, Issue 4, pp. 898 - 907
The occurrence and fate of pharmaceuticals in the aquatic environment is recognized as one of the emerging issues in environmental chemistry and as a matter of... 
Environment, general | Cross-flow ultrafiltration | Aquatic colloids | Environment | Liquid chromatography-tandem mass spectrometry | Waste Water Technology / Water Pollution Control / Water Management / Aquatic Pollution | Industrial Pollution Prevention | Atmospheric Protection/Air Quality Control/Air Pollution | Effluent | Pharmaceuticals | ENDOCRINE-DISRUPTING CHEMICALS | RIVER WATER | WASTE-WATER TREATMENT | PERSONAL CARE PRODUCTS | SEWAGE-TREATMENT PLANTS | TANDEM MASS-SPECTROMETRY | ENVIRONMENTAL SCIENCES | ACTIVATED-SLUDGE TREATMENT | REMOVAL | SOLID-PHASE EXTRACTION | Colloids - chemistry | Fresh Water - chemistry | Propranolol - analysis | Diclofenac - chemistry | Sulfamethoxazole - analysis | Carbamazepine - chemistry | Tamoxifen - chemistry | Thioridazine - chemistry | Indomethacin - analysis | Phenethylamines - analysis | Sewage - chemistry | Carbamazepine - analysis | Phenethylamines - chemistry | Water Pollutants, Chemical - chemistry | Propranolol - chemistry | Environmental Restoration and Remediation - methods | Water Pollutants, Chemical - analysis | Meclofenamic Acid - chemistry | Tamoxifen - analysis | Sulfamethoxazole - chemistry | Meclofenamic Acid - analysis | Diclofenac - analysis | Pharmaceutical Preparations - chemistry | Indomethacin - chemistry | Thioridazine - analysis | Pharmaceutical Preparations - analysis | Propranolol hydrochloride | Sewage | Purification | Analysis | Green technology | Water, Underground | Air pollution | Tamoxifen | Mass spectrometry | Sediments (Geology) | Carbamazepine | Water pollution | Bioavailability | Risk assessment | Water quality | Index Medicus
Journal Article
2006, 1. Aufl., Ernst Schering Research Foundation Workshop, ISBN 9783540278658, Volume 58., xiv, 173
Chemical genomics is a highly interdisciplinary and very exciting field of research both in academics and in the life sciences industry. The Ernst Schering... 
Chemogenomics | Pharmacogenetics | Genomics | Proteomics | Medicine | Medicinal Chemistry | Biochemistry, general | Chemistry | Molecular Medicine | Pharmacology/Toxicology | Biomedicine general | Organic Chemistry
Book
Journal Article
Journal of Pharmacy and Pharmacology, ISSN 0022-3573, 11/2018, Volume 70, Issue 11, pp. 1474 - 1484
ObjectiveWe synthesized new tamoxifen derivatives as anticancer drug candidates and elaborated on convection-enhanced delivery (CED) as a strategy for... 
ferrocenyl‐tamoxifen derivatives | breast cancer | polymer nanocapsules | glioblastoma | Lipid nanocapsules | ferrocenyl-tamoxifen derivatives | PHARMACOLOGY & PHARMACY | Chemistry, Pharmaceutical - methods | Apoptosis - drug effects | Humans | Rats, Inbred F344 | Brain Neoplasms - pathology | Nanocapsules | Male | Antineoplastic Agents - administration & dosage | Drug Carriers | Lipids - chemistry | Tamoxifen - chemical synthesis | Drug Compounding | Female | Solubility | Antineoplastic Agents - chemistry | Brain Neoplasms - drug therapy | Breast Neoplasms - drug therapy | Polyesters - chemistry | Animals | Breast Neoplasms - pathology | Glioblastoma - pathology | Tamoxifen - pharmacology | Cell Line, Tumor | Drug Liberation | Tamoxifen - analogs & derivatives | Cell Proliferation - drug effects | Kinetics | Cell Cycle - drug effects | Glioblastoma - drug therapy | Encapsulation | Drugs | Brain | Drug delivery systems | Toxicity | Glioblastoma | Lipids | Esters | Drug development | Convection | Metastases | Anticancer properties | Cell cycle | Formulations | Prodrugs | Astrocytes | Breast cancer | Derivatives | Tamoxifen | Chemical compounds | Esterification | Organic chemistry | Breast | Glioblastoma cells | Cancer | Apoptosis | Index Medicus | Medicinal Chemistry | Life Sciences | Chemical Sciences | Coordination chemistry | Pharmaceutical sciences
Journal Article
Journal of Controlled Release, ISSN 0168-3659, 12/2015, Volume 220, Issue Pt B, pp. 751 - 757
We report the synthesis and encapsulation of polyester nanosponge particles (NPs) co-loaded with tamoxifen (TAM) and quercetin (QT) to investigate the loading,... 
Drug metabolism | Nanoparticle drug delivery | Chemotherapy | Combination therapy | Tamoxifen | Quercetin | ANGIOGENESIS | CHEMISTRY, MULTIDISCIPLINARY | BIOAVAILABILITY | PACLITAXEL | BREAST-CANCER | COLON-CANCER | NANOPARTICLES | IN-VITRO | INHIBITION | PHARMACOLOGY & PHARMACY | RING-OPENING POLYMERIZATION | TARGETED DELIVERY | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - chemistry | Biological Availability | Gastric Juice - chemistry | Tamoxifen - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Breast Neoplasms - metabolism | Drug Carriers | Intestinal Secretions - chemistry | Dose-Response Relationship, Drug | Nanoparticles | Biotransformation | Tamoxifen - chemistry | Quercetin - administration & dosage | Female | Tamoxifen - metabolism | Cell Survival - drug effects | Antineoplastic Combined Chemotherapy Protocols - metabolism | Cross-Linking Reagents - chemistry | Quercetin - chemistry | Drug Stability | Solubility | Breast Neoplasms - drug therapy | Chemistry, Pharmaceutical | Particle Size | Polyesters - chemistry | Animals | Glucuronosyltransferase - metabolism | Quercetin - pharmacology | Breast Neoplasms - pathology | Cytochrome P-450 CYP3A - metabolism | Nanomedicine - methods | Tamoxifen - pharmacology | Cell Line, Tumor | Mice | Kinetics | Delayed-Action Preparations | Quercetin - metabolism | Drugs | Physiological aspects | Drug delivery systems | Crosslinked polymers | Vehicles | Index Medicus
Journal Article
15.